SOCIETY: AGA This session highlights the latest research on novel prediction models in IBD as well as the role of the fecal microbiome and imaging in IBD.

Presentations:

DEVELOPMENT AND VALIDATION OF AN INTEGRATED RISK SCORE FOR PREDICTING FUTURE RISK OF CROHN'S DISEASE UP TO 7 YEARS BEFORE DIAGNOSIS IN HEALTHY FIRST-DEGREE RELATIVES: THE CCC-GEM PROJECT, A MULTICENTRE PROSPECTIVE COHORT STUDY

FAECAL MICROBIOME AS TARGETED NON-INVASIVE BIOMARKERS FOR INFLAMMATORY BOWEL DISEASE: A CROSS-POPULATION METAGENOMIC ANALYSIS IN SIX COHORTS

COMPARISON OF DIAGNOSTIC ACCURACY BETWEEN CROSS SECTIONAL IMAGING TECHNIQUES AND SMALL INTESTINAL CONTRAST ULTRASONOGRAPHY IN SMALL BOWEL CROHN’S DISEASE (THE CACTUS-CD TRIAL) : A PAIRED VALIDATING CONFIRMATORY STUDY

EARLY INTESTINAL ULTRASOUND RESPONSE TO BIOLOGIC AND SMALL MOLECULE THERAPY PREDICTS ENDOSCOPIC OUTCOMES IN CHILDREN WITH ULCERATIVE COLITIS

A CLINICAL SCORE FOR UC2CD, A NOVEL SUBGROUP IN INFLAMMATORY BOWEL DISEASES (IBD) WITH DISTINCT SEROLOGICAL, GENETIC AND CLINICAL FEATURES

SIMPLE ENDOSCOPIC SCORE FOR CROHN’S DISEASE (SES-CD) ≥ 7 PREDICTS DISEASE PROGRESSION IN PATIENTS WITH MILD CD

Jellyana Peraza

Appearances